1
|
Swan D, Enright H, Desmond R, Le G, El Hassadi E, Hennessy B, Lynott F, O'Keeffe D, Crowley M, Smyth L, Perera K, Jennings C, Ni Ainle F, Coll J, Ryan K, O'Donnell J, Lavin M, O'Connell N. Vaccine-induced thrombosis and thrombocytopenia (VITT) in Ireland: A review of cases and current practices. Thromb Update 2021; 5:100086. [PMID: 38620810 PMCID: PMC8578028 DOI: 10.1016/j.tru.2021.100086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2021] [Revised: 10/26/2021] [Accepted: 10/27/2021] [Indexed: 11/20/2022] Open
Abstract
Since the beginning of the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2) virus pandemic, several highly effective and safe vaccines have been produced at remarkable speed. Following global implementation of vaccination programmes, cases of thrombosis with thrombocytopenia following administration of adenoviral vector-based vaccines started being reported. In this review we discuss the known pathogenesis and epidemiology of so-called vaccine induced thrombocytopenia and thrombosis (VITT). We consider the available guidelines, diagnostic laboratory tests and management options for these patients. Finally, we discuss important unanswered questions and areas for future research in this novel pathoclinical entity.
Collapse
Affiliation(s)
- D Swan
- National Coagulation Centre, St James' Hospital, Dublin, Ireland
| | - H Enright
- Tallaght University Hospital, Dublin, Ireland
| | - R Desmond
- Tallaght University Hospital, Dublin, Ireland
| | - G Le
- Tallaght University Hospital, Dublin, Ireland
| | - E El Hassadi
- Waterford University Hospital, Waterford, Ireland
| | - B Hennessy
- Waterford University Hospital, Waterford, Ireland
| | - F Lynott
- Waterford University Hospital, Waterford, Ireland
| | - D O'Keeffe
- University Hospital Limerick, Limerick, Ireland
| | - M Crowley
- Cork University Hospital, Cork, Ireland
| | - L Smyth
- St Vincent's University Hospital, Dublin, Ireland
| | - K Perera
- Midland Regional Hospital Tullamore, Tullamore, Ireland
| | - C Jennings
- Midland Regional Hospital Tullamore, Tullamore, Ireland
| | - F Ni Ainle
- Mater Misericordiae University Hospital, Dublin, Ireland
| | - J Coll
- Mater Misericordiae University Hospital, Dublin, Ireland
| | - K Ryan
- National Coagulation Centre, St James' Hospital, Dublin, Ireland
| | - J O'Donnell
- National Coagulation Centre, St James' Hospital, Dublin, Ireland
| | - M Lavin
- National Coagulation Centre, St James' Hospital, Dublin, Ireland
| | - N O'Connell
- National Coagulation Centre, St James' Hospital, Dublin, Ireland
| |
Collapse
|
2
|
Kerr GM, Crowley M, O'Reilly EJ, Cunningham C. Justifying quarantine in preventing the spread of COVID-19 in healthcare. Occup Med (Lond) 2021; 71:250-254. [PMID: 34455444 PMCID: PMC8499754 DOI: 10.1093/occmed/kqab077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Background The first COVID-19-positive patient was identified in Ireland on 29 February 2020 (Department of Health, Government of Ireland; https://www.gov.ie/en/pressrelease/2f75fd-statement-from-the-national-public-healthemergency-team-sat-29-feb/). Healthcare worker (HCW) quarantining became a core intervention for those identified as ‘close contacts’ to reduce onward transmission within the workplace to patients and colleagues. Whether a quarantining strategy could be justified at a time when there was an increased demand for the services of HCWs remained unknown. Aims To establish whether quarantining staff away from a healthcare setting during a pandemic is justified. Methods This retrospective study examined close contacts of COVID-19-positive index cases (both residents and HCWs) in a community hospital over a 4-week period from 1 to 28 April 2020. Close contacts were identified in accordance with national guidelines. Zones of the hospital were examined to determine the number of COVID-positive index cases and their close contacts. A cumulative result for the hospital was recorded. Results While outcomes varied over time, per zone and per HCW category, the overall conversion rate from close contact to an index case was 30%. Conclusions This study vindicates the policy of quarantining close contact HCWs from their workplaces as they pose a significant threat to both their patients and fellow workers.
Collapse
Affiliation(s)
- G M Kerr
- Occupational Health Department, Cork University Hospital, HSE South, Cork T12AK54, Ireland
| | - M Crowley
- Risk Management, Cork University Hospital, Cork, Ireland
| | - E J O'Reilly
- School of Public Health, University College Cork, Cork T12AK54, Ireland
| | - C Cunningham
- School of Public Health, University College Cork, Cork T12AK54, Ireland
| |
Collapse
|
3
|
Lehane M, Connolly S, Crowley M, Hart C, O"flynn AM. Kidney function decline in heart failure patients: an audit of out-patient heart failure services. Eur J Cardiovasc Nurs 2021. [DOI: 10.1093/eurjcn/zvab060.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
A bidirectional relationship exists between the kidney and the heart; the lower the eGFR the more challenging it is to manage the heart failure (HF) patient. Worsening renal function is common in HF patients and associated with a two-fold increase in mortality and a lower likelihood of being prescribed efficacious HF therapy. The role of cardio-renal interactions in HF is essential to identify risk and subsequent treatment strategies.
Purpose
The purpose of this audit is to provide insights into the assessment of renal function in a real world heart failure population by identifying the degree of renal dysfunction and changes in renal function over a five year time frame.
Methods
A retrospective audit included patients with HFrEF attending a heart failure service. These patients were classified using KIDGO criteria CKD 1-5. A current eGFR sample was compared with a sample taken five years earlier, identified using the electronic laboratory record. Ethical approval was granted from the Research Ethics Committee.
Resultss
100 patients with HFrEF attending a heart failure service fulfilled the selection criteria of which sixty three patients with an eGFR >60ml/min/1.73 m2 were audited. Of this group 43 were CKD class 2 and 20 were CKD class 1. Thirty seven patients had an eGFR <60ml/min/1.73 m2 of which 9 were class 3b, 9 were CKD class 4 and 1 was CKD Class 5.
Of the 100 patients enrolled, 6 were excluded from the analysis of kidney function decline as an eGFR from five years earlier was unavailable. Within a five year time span, 44 patients did not change their CKD class, 31 patients declined by one class, 9 patients declined by two classes, 3 patients declined by three classes and 7 patients improved their kidney function.
GFR < 60mL/min/1.73m2,
n = 37
GFR > 60mL/min/1.73m2, n = 63
Age – mean (range)
77.8 (49-94)
66.5 (45-89)
Gender – female (%)
12 (32%)
16 (25%)
Average renal function measurements (mean, range)
6.4
6.7
Total albumin
creatinine ratio measurements
8
6
Actively attending renal service
6
0
Conclusion
Nurses should be aware of the increasing risk conferred by the dual diagnosis of heart failure and chronic kidney disease. Patients with heart failure who have decreasing eGFR levels (especially less than 30 mL/min), should have collaborative management with nephrology services to optimise outcomes. Recognition of CKD in our institution and referral to nephrology services was suboptimal and further work is necessary to optimise the management of these patients.
Collapse
Affiliation(s)
- M Lehane
- Mallow General Hospital, Heart Failure Unit, Cork, Ireland
| | - S Connolly
- Mallow General Hospital, Heart Failure Unit, Cork, Ireland
| | - M Crowley
- Mallow General Hospital, Heart Failure Unit, Cork, Ireland
| | - C Hart
- Mallow General Hospital, Heart Failure Unit, Cork, Ireland
| | - AM O"flynn
- Mallow General Hospital, Heart Failure Unit, Cork, Ireland
| |
Collapse
|
4
|
Mainolfi N, Ehara T, Karki RG, Anderson K, Mac Sweeney A, Liao SM, Argikar UA, Jendza K, Zhang C, Powers J, Klosowski DW, Crowley M, Kawanami T, Ding J, April M, Forster C, Serrano-Wu M, Capparelli M, Ramqaj R, Solovay C, Cumin F, Smith TM, Ferrara L, Lee W, Long D, Prentiss M, De Erkenez A, Yang L, Liu F, Sellner H, Sirockin F, Valeur E, Erbel P, Ostermeier D, Ramage P, Gerhartz B, Schubart A, Flohr S, Gradoux N, Feifel R, Vogg B, Wiesmann C, Maibaum J, Eder J, Sedrani R, Harrison RA, Mogi M, Jaffee BD, Adams CM. Discovery of 4-((2 S,4 S)-4-Ethoxy-1-((5-methoxy-7-methyl-1 H-indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases. J Med Chem 2020; 63:5697-5722. [PMID: 32073845 DOI: 10.1021/acs.jmedchem.9b01870] [Citation(s) in RCA: 20] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
The alternative pathway (AP) of the complement system is a key contributor to the pathogenesis of several human diseases including age-related macular degeneration, paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and various glomerular diseases. The serine protease factor B (FB) is a key node in the AP and is integral to the formation of C3 and C5 convertase. Despite the prominent role of FB in the AP, selective orally bioavailable inhibitors, beyond our own efforts, have not been reported previously. Herein we describe in more detail our efforts to identify FB inhibitors by high-throughput screening (HTS) and leveraging insights from several X-ray cocrystal structures during optimization efforts. This work culminated in the discovery of LNP023 (41), which is currently being evaluated clinically in several diverse AP mediated indications.
Collapse
Affiliation(s)
- Nello Mainolfi
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| | - Takeru Ehara
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| | - Rajeshri G Karki
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| | - Karen Anderson
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| | - Aengus Mac Sweeney
- Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4056 Basel, Switzerland
| | - Sha-Mei Liao
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| | - Upendra A Argikar
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| | - Keith Jendza
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| | - Chun Zhang
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| | - James Powers
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| | - Daniel W Klosowski
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| | - Maura Crowley
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| | - Toshio Kawanami
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| | - Jian Ding
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| | - Myriam April
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| | - Cornelia Forster
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| | - Michael Serrano-Wu
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| | - Michael Capparelli
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| | - Rrezarta Ramqaj
- Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4056 Basel, Switzerland
| | - Catherine Solovay
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| | - Frederic Cumin
- Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4056 Basel, Switzerland
| | - Thomas M Smith
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| | - Luciana Ferrara
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| | - Wendy Lee
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| | - Debby Long
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| | - Melissa Prentiss
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| | - Andrea De Erkenez
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| | - Louis Yang
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| | - Fang Liu
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| | - Holger Sellner
- Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4056 Basel, Switzerland
| | - Finton Sirockin
- Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4056 Basel, Switzerland
| | - Eric Valeur
- Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4056 Basel, Switzerland
| | - Paulus Erbel
- Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4056 Basel, Switzerland
| | - Daniela Ostermeier
- Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4056 Basel, Switzerland
| | - Paul Ramage
- Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4056 Basel, Switzerland
| | - Bernd Gerhartz
- Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4056 Basel, Switzerland
| | - Anna Schubart
- Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4056 Basel, Switzerland
| | - Stefanie Flohr
- Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4056 Basel, Switzerland
| | - Nathalie Gradoux
- Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4056 Basel, Switzerland
| | - Roland Feifel
- Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4056 Basel, Switzerland
| | - Barbara Vogg
- Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4056 Basel, Switzerland
| | - Christian Wiesmann
- Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4056 Basel, Switzerland
| | - Jürgen Maibaum
- Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4056 Basel, Switzerland
| | - Jörg Eder
- Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4056 Basel, Switzerland
| | - Richard Sedrani
- Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4056 Basel, Switzerland
| | - Richard A Harrison
- Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4056 Basel, Switzerland
| | - Muneto Mogi
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| | - Bruce D Jaffee
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| | - Christopher M Adams
- Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States
| |
Collapse
|
5
|
Karki RG, Powers J, Mainolfi N, Anderson K, Belanger DB, Liu D, Ji N, Jendza K, Gelin CF, Mac Sweeney A, Solovay C, Delgado O, Crowley M, Liao SM, Argikar UA, Flohr S, La Bonte LR, Lorthiois EL, Vulpetti A, Brown A, Long D, Prentiss M, Gradoux N, de Erkenez A, Cumin F, Adams C, Jaffee B, Mogi M. Design, Synthesis, and Preclinical Characterization of Selective Factor D Inhibitors Targeting the Alternative Complement Pathway. J Med Chem 2019; 62:4656-4668. [PMID: 30995036 DOI: 10.1021/acs.jmedchem.9b00271] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
Complement factor D (FD), a highly specific S1 serine protease, plays a central role in the amplification of the alternative complement pathway (AP) of the innate immune system. Dysregulation of AP activity predisposes individuals to diverse disorders such as age-related macular degeneration, atypical hemolytic uremic syndrome, membranoproliferative glomerulonephritis type II, and paroxysmal nocturnal hemoglobinuria. Previously, we have reported the screening efforts and identification of reversible benzylamine-based FD inhibitors (1 and 2) binding to the open active conformation of FD. In continuation of our drug discovery program, we designed compounds applying structure-based approaches to improve interactions with FD and gain selectivity against S1 serine proteases. We report herein the design, synthesis, and medicinal chemistry optimization of the benzylamine series culminating in the discovery of 12, an orally bioavailable and selective FD inhibitor. 12 demonstrated systemic suppression of AP activation in a lipopolysaccharide-induced AP activation model as well as local ocular suppression in intravitreal injection-induced AP activation model in mice expressing human FD.
Collapse
Affiliation(s)
- Rajeshri G Karki
- Novartis Institutes for BioMedical Research , Cambridge , Massachusetts 02139 , United States
| | - James Powers
- Novartis Institutes for BioMedical Research , Cambridge , Massachusetts 02139 , United States
| | - Nello Mainolfi
- Novartis Institutes for BioMedical Research , Cambridge , Massachusetts 02139 , United States
| | - Karen Anderson
- Novartis Institutes for BioMedical Research , Cambridge , Massachusetts 02139 , United States
| | - David B Belanger
- Novartis Institutes for BioMedical Research , Cambridge , Massachusetts 02139 , United States
| | - Donglei Liu
- Novartis Institutes for BioMedical Research , Cambridge , Massachusetts 02139 , United States
| | - Nan Ji
- Novartis Institutes for BioMedical Research , Cambridge , Massachusetts 02139 , United States
| | - Keith Jendza
- Novartis Institutes for BioMedical Research , Cambridge , Massachusetts 02139 , United States
| | - Christine F Gelin
- Novartis Institutes for BioMedical Research , Cambridge , Massachusetts 02139 , United States
| | - Aengus Mac Sweeney
- Novartis Institutes for BioMedical Research , Novartis Campus , CH-4056 Basel , Switzerland
| | - Catherine Solovay
- Novartis Institutes for BioMedical Research , Cambridge , Massachusetts 02139 , United States
| | - Omar Delgado
- Novartis Institutes for BioMedical Research , Cambridge , Massachusetts 02139 , United States
| | - Maura Crowley
- Novartis Institutes for BioMedical Research , Cambridge , Massachusetts 02139 , United States
| | - Sha-Mei Liao
- Novartis Institutes for BioMedical Research , Cambridge , Massachusetts 02139 , United States
| | - Upendra A Argikar
- Novartis Institutes for BioMedical Research , Cambridge , Massachusetts 02139 , United States
| | - Stefanie Flohr
- Novartis Institutes for BioMedical Research , Novartis Campus , CH-4056 Basel , Switzerland
| | - Laura R La Bonte
- Novartis Institutes for BioMedical Research , Cambridge , Massachusetts 02139 , United States
| | - Edwige L Lorthiois
- Novartis Institutes for BioMedical Research , Novartis Campus , CH-4056 Basel , Switzerland
| | - Anna Vulpetti
- Novartis Institutes for BioMedical Research , Novartis Campus , CH-4056 Basel , Switzerland
| | - Ann Brown
- Novartis Institutes for BioMedical Research , Cambridge , Massachusetts 02139 , United States
| | - Debby Long
- Novartis Institutes for BioMedical Research , Cambridge , Massachusetts 02139 , United States
| | - Melissa Prentiss
- Novartis Institutes for BioMedical Research , Cambridge , Massachusetts 02139 , United States
| | - Nathalie Gradoux
- Novartis Institutes for BioMedical Research , Novartis Campus , CH-4056 Basel , Switzerland
| | - Andrea de Erkenez
- Novartis Institutes for BioMedical Research , Cambridge , Massachusetts 02139 , United States
| | - Frederic Cumin
- Novartis Institutes for BioMedical Research , Novartis Campus , CH-4056 Basel , Switzerland
| | - Christopher Adams
- Novartis Institutes for BioMedical Research , Cambridge , Massachusetts 02139 , United States
| | - Bruce Jaffee
- Novartis Institutes for BioMedical Research , Cambridge , Massachusetts 02139 , United States
| | - Muneto Mogi
- Novartis Institutes for BioMedical Research , Cambridge , Massachusetts 02139 , United States
| |
Collapse
|
6
|
Appleby N, Groarke E, Crowley M, Wahab FA, McCann AM, Egan L, Gough D, McMahon G, O'Donghaile D, O'Keeffe D, O'Connell N. Reversal of warfarin anticoagulation using prothrombin complex concentrate at 25 IU kg−1: results of the RAPID study. Transfus Med 2016; 27:66-71. [DOI: 10.1111/tme.12371] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2016] [Revised: 09/19/2016] [Accepted: 09/19/2016] [Indexed: 11/27/2022]
Affiliation(s)
- N. Appleby
- Department of Haematology; St James's University Hospital; Dublin Ireland
| | - E. Groarke
- Department of Haematology; Limerick University Hospital; Limerick Ireland
| | - M. Crowley
- Department of Haematology; St James's University Hospital; Dublin Ireland
| | - F. A. Wahab
- Department of Haematology; Limerick University Hospital; Limerick Ireland
| | - A. M. McCann
- Department of Haematology; St James's University Hospital; Dublin Ireland
| | - L. Egan
- Department of Haematology; St James's University Hospital; Dublin Ireland
| | - D. Gough
- Department of Haematology; St James's University Hospital; Dublin Ireland
| | - G. McMahon
- Department of Emergency Medicine; St. James's University Hospital; Dublin Ireland
| | - D. O'Donghaile
- Department of Haematology; St James's University Hospital; Dublin Ireland
| | - D. O'Keeffe
- Department of Haematology; Limerick University Hospital; Limerick Ireland
| | - N. O'Connell
- Department of Haematology; St James's University Hospital; Dublin Ireland
| |
Collapse
|
7
|
Rainey SR, Simpson J, Page S, Crowley M, Evans J, Sheridan M, Ireland AJ. The impact of violence reduction initiatives on emergency department attendance. Scott Med J 2016; 60:90-4. [PMID: 25922413 DOI: 10.1177/0036933015576297] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND Recent violence reduction initiatives in Glasgow have led to a reduction in recorded levels of violent crime.(1) This study evaluates the impact of these initiatives on assault-related emergency department attendances and admissions. METHODS A retrospective observational study conducted in Glasgow Royal Infirmary's emergency department comparing assault-related emergency department attendances and hospital admissions over two 30-day study periods (April 2010 and April 2012). The primary outcome measure was the change in assault-related emergency department attendances. The secondary outcome measure was the impact on assault-related hospital and critical care admissions. RESULTS In April 2010, there were 6098 emergency department attendances, 301 (4.9%) were due to assault. In April 2012, there were 7236 emergency department attendances, 263 (3.6%) were due to assault, representing a significant reduction in assault-related attendances (p < 0.01). There were significant reductions in level 1 admissions 2010 n = 56 (19.2%), 2012 n = 36 (14.0%) p = 0.04 and critical care admissions, 2010 n = 5 (1.7%), 2012 n = 1 (0.4%) p = 0.04. CONCLUSIONS Violence reduction initiatives in Glasgow have contributed to a reduction in assault-related emergency department attendance at Glasgow Royal Infirmary. The reduction in hospital admissions, in particular critical care admissions, suggests a reduction in morbidity and cost to the National Health Service.
Collapse
Affiliation(s)
- S R Rainey
- Emergency Medicine Registrar, Emergency Department, Glasgow Royal Infirmary, UK
| | - J Simpson
- GPST1, Emergency Department, Glasgow Royal Infirmary, UK
| | - S Page
- FY2, Emergency Department, Glasgow Royal Infirmary, UK
| | - M Crowley
- Medical Student, Emergency Department, Glasgow Royal Infirmary, UK
| | - J Evans
- Reader in Public Health, School of Health Sciences, Stirling University, UK
| | - M Sheridan
- Emergency Medicine Consultant, Emergency Department, Glasgow Royal Infirmary, UK
| | - A J Ireland
- Emergency Medicine Consultant, Emergency Department, Glasgow Royal Infirmary, UK
| |
Collapse
|
8
|
Gounarides J, Cobb JS, Zhou J, Cook F, Yang X, Yin H, Meredith E, Rao C, Huang Q, Xu Y, Anderson K, De Erkenez A, Liao SM, Crowley M, Buchanan N, Poor S, Qiu Y, Fassbender E, Shen S, Woolfenden A, Jensen A, Cepeda R, Etemad-Gilbertson B, Giza S, Mogi M, Jaffee B, Azarian S. Lack of involvement of CEP adducts in TLR activation and in angiogenesis. PLoS One 2014; 9:e111472. [PMID: 25343517 PMCID: PMC4208838 DOI: 10.1371/journal.pone.0111472] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2013] [Accepted: 10/02/2014] [Indexed: 11/19/2022] Open
Abstract
Proteins that are post-translationally adducted with 2-(ω-carboxyethyl)pyrrole (CEP) have been proposed to play a pathogenic role in age-related macular degeneration, by inducing angiogenesis in a Toll Like Receptor 2 (TLR2)-dependent manner. We have investigated the involvement of CEP adducts in angiogenesis and TLR activation, to assess the therapeutic potential of inhibiting CEP adducts and TLR2 for ocular angiogenesis. As tool reagents, several CEP-adducted proteins and peptides were synthetically generated by published methodology and adduction was confirmed by NMR and LC-MS/MS analyses. Structural studies showed significant changes in secondary structure in CEP-adducted proteins but not the untreated proteins. Similar structural changes were also observed in the treated unadducted proteins, which were treated by the same adduction method except for one critical step required to form the CEP group. Thus some structural changes were unrelated to CEP groups and were artificially induced by the synthesis method. In biological studies, the CEP-adducted proteins and peptides failed to activate TLR2 in cell-based assays and in an in vivo TLR2-mediated retinal leukocyte infiltration model. Neither CEP adducts nor TLR agonists were able to induce angiogenesis in a tube formation assay. In vivo, treatment of animals with CEP-adducted protein had no effect on laser-induced choroidal neovascularization. Furthermore, in vivo inactivation of TLR2 by deficiency in Myeloid Differentiation factor 88 (Myd88) had no effect on abrasion-induced corneal neovascularization. Thus the CEP-TLR2 axis, which is implicated in other wound angiogenesis models, does not appear to play a pathological role in a corneal wound angiogenesis model. Collectively, our data do not support the mechanism of action of CEP adducts in TLR2-mediated angiogenesis proposed by others.
Collapse
Affiliation(s)
- John Gounarides
- Analytical Sciences, Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America
| | - Jennifer S. Cobb
- Analytical Sciences, Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America
| | - Jing Zhou
- Analytical Sciences, Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America
| | - Frank Cook
- Analytical Sciences, Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America
| | - Xuemei Yang
- Analytical Sciences, Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America
| | - Hong Yin
- Analytical Sciences, Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America
| | - Erik Meredith
- Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America
| | - Chang Rao
- Analytical Sciences, Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America
| | - Qian Huang
- Developmental and Metabolic Pathways, Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America
| | - YongYao Xu
- Developmental and Metabolic Pathways, Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America
| | - Karen Anderson
- Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America
| | - Andrea De Erkenez
- Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America
| | - Sha-Mei Liao
- Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America
| | - Maura Crowley
- Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America
| | - Natasha Buchanan
- Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America
| | - Stephen Poor
- Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America
| | - Yubin Qiu
- Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America
| | - Elizabeth Fassbender
- Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America
| | - Siyuan Shen
- Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America
| | - Amber Woolfenden
- Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America
| | - Amy Jensen
- Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America
| | - Rosemarie Cepeda
- Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America
| | - Bijan Etemad-Gilbertson
- Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America
| | - Shelby Giza
- Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America
| | - Muneto Mogi
- Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America
| | - Bruce Jaffee
- Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America
| | - Sassan Azarian
- Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America
- * E-mail:
| |
Collapse
|
9
|
Buitrago D, Keutgen XM, Crowley M, Filicori F, Aldailami H, Hoda R, Liu YF, Hoda RS, Scognamiglio T, Jin M, Fahey TJ, Zarnegar R. Intercellular adhesion molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma. Ann Surg Oncol 2011; 19:973-80. [PMID: 21879273 DOI: 10.1245/s10434-011-2029-0] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2011] [Indexed: 01/08/2023]
Abstract
BACKGROUND Intercellular adhesion molecule-1 (ICAM-1) is implicated in carcinogenesis. In this study we examined the expression of ICAM-1 in papillary thyroid cancer (PTC). We hypothesized that ICAM-1 correlates with indicators of tumor aggressiveness in PTC. METHODS Thirty-five primary and metastatic PTCs, five follicular adenomas, five Hashimoto thyroiditis, five nodular hyperplasia, and eight normal thyroid tissue samples were analyzed for ICAM-1 gene expression using quantitative reverse-transcription polymerase chain reaction (RT-PCR). ICAM-1 gene expression was analyzed at protein level by immunohistochemistry (IHC) using a semiquantitative score. Gene expression and intensity levels were correlated with markers of tumor aggressiveness including BRAF V600E mutation, tumor size, extrathyroidal extension (ETE), angiolymphatic invasion, and lymph node metastasis. RESULTS ICAM-1 gene expression was higher in PTC (p = 0.01) and lymph node metastases (p = 0.03) when compared with benign tumors and Hashimoto's. Furthermore, PTCs exhibiting BRAF V600E mutation (p = 0.01), ETE (p < 0.01), and lymph node metastasis (p = 0.02) were associated with higher ICAM-1 levels. Gene expression correlated with protein levels on IHC. Additionally, poorly differentiated thyroid carcinoma had a higher ICAM-1 intensity score compared with well-differentiated carcinoma (p = 0.03). CONCLUSIONS ICAM-1 expression is upregulated in papillary thyroid carcinoma. Furthermore, ICAM-1 upregulation correlated with aggressive tumor features such as BRAF V600E mutation, ETE, and lymph node metastasis, suggesting that ICAM-1 plays a role in thyroid cancer progression.
Collapse
Affiliation(s)
- D Buitrago
- Division of Endocrine and Minimally Invasive Surgery, Department of Surgery, New York Presbyterian Hospital-Weill Cornell Medical College, New York, USA
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Murphy AG, Roberts-Thomson R, O'Sullivan-Coyne G, Crowley M, Bystricky B, Moylan E, O'Reilly S. Multicenter review of fertility preservation and contraceptive information provided to cancer patients. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e19640] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
11
|
Urbanic J, Clark H, Chiles C, Case D, Hinson W, Hampton C, Kearns W, Crowley M, Clark P, Blackstock A. Initial Toxicity Report of a Phase II Study of Radiofrequency Ablation Combined with External Beam Radiation Therapy for Patients with Medically Inoperable Non–small Cell Lung Cancer (Stages IA and Select B). Int J Radiat Oncol Biol Phys 2009. [DOI: 10.1016/j.ijrobp.2009.07.1011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
12
|
Crowley M, Asif P, D'Souza G. 70. Evaluation of the Incidence of Intra-Vascular Needle Placement for Single Shot Lumbar Plexus Blockade. Reg Anesth Pain Med 2008. [DOI: 10.1136/rapm-00115550-200809001-00198] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
13
|
Crowley M, Asif P, D'Souza G. 78. Electrocardiogram (ECG) Monitor “Pacing” Interference from a Peripheral Nerve Stimulator When Performing a Peripheral Nerve Block. Reg Anesth Pain Med 2008. [DOI: 10.1136/rapm-00115550-200809001-00164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
14
|
D'Souza G, Crowley M, Asif P. 180. Evaluation of Chronic Pain Consultant Workforce Requirements Over a Six Year Period in the UK: A 2008 Update. Reg Anesth Pain Med 2008. [DOI: 10.1136/rapm-00115550-200809001-00401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
15
|
Piccin A, O'Marcaigh A, Smith O, O'Riordan J, Crowley M, Vandenberg E, Gardiner N, McCann S. Outcome of bone marrow transplantation in acquired and inherited aplastic anaemia in the Republic of Ireland. Ir J Med Sci 2005; 174:13-9. [PMID: 16285332 DOI: 10.1007/bf03169141] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
BACKGROUND Severe Aplastic Anaemia (SAA) and Fanconi Anaemia (FA) are rare haematological disorders characterised by pancytopenia and bone marrow hypoplasia. AIMS We performed a retrospective study of all patients who underwent BMT for SAA and FA at St James's Hospital, Dublin, and at OLHSC, Crumlin, between 1985 and 2002. METHODS The medical records of 63 patients, 50 with acquired SAA and 13 with FA, were reviewed. RESULTS The median age at the time of transplant was 14 years (range 3-43 years). The actuarial survival (OS) (n = 63) was 76% at 17 years. The transplant related mortality (TRM) was 22% (n = 14). The most common cause of death was infection (46%). The survival was significantly better in patients receiving their transplant after 1995 (p = 0.002). Outcome was superior in those receiving less than 20 red cell transfusions prior to transplant: OS 91% (< 20 Units) versus 62% (> or = 20 Units). CONCLUSIONS These national results are comparable to those of published international series and support the use of BMT in the treatment of SAA and FA. The known adverse effect of prior transfusion was confirmed.
Collapse
Affiliation(s)
- A Piccin
- Trinity Centre, St James's Hospital, Dublin.
| | | | | | | | | | | | | | | |
Collapse
|
16
|
Hayden PJ, Keogh F, Ni Conghaile M, Carroll M, Crowley M, Fitzsimon N, Gardiner N, Vandenberghe E, O'Riordan J, McCann SR. A single-centre assessment of long-term quality-of-life status after sibling allogeneic stem cell transplantation for chronic myeloid leukaemia in first chronic phase. Bone Marrow Transplant 2005; 34:545-56. [PMID: 15343272 DOI: 10.1038/sj.bmt.1704638] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
A total of 75 patients underwent sibling allogeneic stem cell transplantation (SCT) for chronic myeloid leukaemia in first chronic phase from 1984 to 2000. Of these patients, 51 (68%) were alive at a median follow-up of 98 months (range 34-217 months). Nine (18%) patients relapsed and seven (14%) received donor lymphocyte transfusions. Quality of life (QoL) was assessed cross-sectionally using the EORTC QLQ-C30, a Leukaemia-BMT-specific module and questionnaires on sexual functioning, fertility and late effects. A total of 46 (90%) replied. Scores for Role (P=0.018) and Cognitive (P<0.001) function were significantly lower when compared to an age-adjusted general population. Dyspnoea (P=0.022) and Financial Difficulties (P<0.001) were significantly more common in the SCT group. No difference was found for scores in the Physical, Emotional and Social domains or the overall Global Health Status/QoL. Decreased sexual functioning was found in one-third of respondents. Although most BMT recipients reported a good QoL, a minority have difficulty with reintegration into professional roles and consequent monetary problems. Identified cognitive and sexual impairments highlight the need for long-term access to psychosocial support.
Collapse
Affiliation(s)
- P J Hayden
- Department of Haematology, St James's Hospital and University of Dublin, Trinity College, Dublin, Ireland.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Abstract
OBJECTIVES Ank encodes a transmembrane protein that is involved in pyrophosphate (PPi) transport and mutations in the Ank gene have been associated with pathological mineralization in cartilage and bone. To understand how Ank works in normal skeletal development it is also important to know which cells within the developing skeleton express Ank. To this end, we examined the expression pattern of Ank mRNA during mouse embryonic development as well as in mouse hind limb joints with emphasis on the period when articular cartilage forms. Since it was previously shown that TGF-beta regulates PPi transport in cells in culture, we also tested the hypothesis that TGF-beta regulates Ank expression. METHODS The localization of Ank mRNA was determined by radioactive in situ hybridization in E15.5 and E17.5 mouse embryos as well as in 1 and 3 week post-natal mice. Ank expression was compared to that of other cartilage markers. In situ hybridization and semi-quantitative RT-PCR were used to determine the effects of TGF-beta on Ank expression in metatarsal organ cultures. RESULTS Ank expression was detected at high levels at sites of both endochondral and intramembranous bone development. In endochondral bones, expression was detected in a subset of hypertrophic cells at ossification centers. Expression was also detected in osteogenic/chondrogenic cells of the perichondrium/periosteum lining the metaphysis, an area associated with the formation and extension of the bone collar. High levels of expression were also detected in non-mineralized tissues of the skeletal system including tendons and the superficial layer of the articular cartilage. Treatment with TGF-beta resulted in an approximately four-fold induction of Ank mRNA in prehypertrophic chondrocytes and perichondrium of metatarsal cultures. CONCLUSIONS The expression pattern of Ank suggests an important role both in inhibiting and regulating mineralization in the developing skeletal system. In addition, TGF-beta1 is able to mediate Ank mRNA expression in chondrocytes suggesting a possible role for TGF-beta and Ank in the regulation of normal mineralization.
Collapse
Affiliation(s)
- P Sohn
- Department of Molecular and Cellular Physiology, University of Cincinnati, School of Medicine, OH 45267-0576, USA
| | | | | | | |
Collapse
|
18
|
Brown I, Surtees J, Black G, Hirschmann PN, Haer J, Crowley M, Williams GEO, Black J, Murfin D, Walker-Kinnear M, Hull M, Delaney R, Pritchard G. Frederic Basil Stileman Barkworth Paul Brian Counsell Samuel Wolfe Hirschmann Mohammed Shahbaaz Khan Robert Kenneth McAll Leslie Alexander McDowell George Hay Marshall Walter John Murfin Bruce Drummond Taylor Scott Nigel John Wilson. West J Med 2001. [DOI: 10.1136/bmj.323.7312.577] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
19
|
Colon-Semidey AJ, Marshik P, Crowley M, Katz R, Kelly HW. Correlation between reversibility of airway obstruction and exhaled nitric oxide levels in children with stable bronchial asthma. Pediatr Pulmonol 2000; 30:385-92. [PMID: 11064429 DOI: 10.1002/1099-0496(200011)30:5<385::aid-ppul4>3.0.co;2-#] [Citation(s) in RCA: 45] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Recent trials measuring exhaled nitric oxide (eNO) concentrations have suggested that it may be a useful measure of ongoing airway inflammation in patients with asthma. The purpose of this study was to examine the relationship between eNO levels and baseline as well as postbronchodilator spirometry, a measurement commonly used in the clinical setting to determine the severity of asthma and as a guide to therapeutic decisions. Forty-nine patients between the ages of 5-16 years with physician-diagnosed asthma who attended the pediatric pulmonary clinic for a routine asthma visit with spirometric evaluation were recruited for the study. eNO levels prior to spirometry were obtained before and after receiving inhaled beta(2) agonist. eNO samples were collected in impermeable bags (Tedlar) and assayed within 24 hr by chemiluminescence. Regression analysis was used to assess the relationships between pre- and postbronchodilator eNO and spirometric variables. eNO was also compared in patients receiving and not receiving inhaled corticosteroids (ICS), as well as those whose therapy had been increased after evaluation by a pediatric pulmonologist or allergist. We found no significant difference between the levels of eNO before and after inhalation of beta(2) agonist (P = 0.60 paired t-test). Positive correlation was found between eNO vs. percentage change in FEV(1) (r = 0.35, P = 0.01) and percentage change in FEF(25-75% )(r = 0.29, P = 0.04). A negative correlation was found between prebronchodilator FEV(1) and eNO (r = -0.29, P = 0.03). Patients on ICS had lower mean eNO levels (29.9 vs. 47.6 parts per billion (ppb), P = 0.053) than those not receiving ICS. Patients whose ICS therapy was increased had higher mean eNO levels (47.2 vs. 26.9 ppb, P = 0.018) than those not having ICS therapy increased. We suggest that eNO levels could be a clinically useful measurement of asthma severity and could be used as an adjunct to spirometry to determine appropriate treatment plans. Longitudinal clinical trials are needed to determine if eNO can enhance therapeutic decisions for asthmatic children.
Collapse
Affiliation(s)
- A J Colon-Semidey
- Division of Pulmonary and Critical Care, Department of Pediatrics, University of New Mexico-Health Sciences Center, Albuquerque, New Mexico, USA
| | | | | | | | | |
Collapse
|
20
|
Abstract
A large cohort of rhesus-negative women in Ireland were inadvertently infected with hepatitis C virus following exposure to contaminated anti-D immunoglobulin in 1977-8. This major iatrogenic episode was discovered in 1994. We studied 36 women who had been infected after their first pregnancy, and compared them to an age- and parity-matched control group of rhesus-positive women. The presence of hepatitis C antibody was confirmed in all 36 by enzyme-linked immunosorbent assay and by recombinant immunoblot assay, while 26 (72%) of the cohort were HCV-RNA-positive (type 1b) on PCR testing. In the 20 years post-infection, all members of the study group had at least one pregnancy, and mean parity was 3.5. They had a total of 100 pregnancies and 85 of these went to term. There were four premature births, one being a twin pregnancy, and 11 spontaneous miscarriages. One miscarriage occurred in the pregnancy following HCV infection. There were two neonatal deaths due to severe congenital abnormalities in the PCR-positive women. Of the children born to HCV-RNA positive mothers, only one (2.3%) tested positive for the virus. Significant portal fibrosis on liver biopsy was confined to HCV-RNA-positive mothers apart from one single exception in the antibody-positive HCV-RNA-negative group. Comparison with the control group showed no increase in spontaneous miscarriage rate, and no significant difference in obstetric complications; birth weights were similar for the two groups.
Collapse
Affiliation(s)
- T Jabeen
- Departments of Medicine, Pathology, and Statistics, Cork University Hospital, and University College Cork, Cork, Ireland
| | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Bursey F, Crowley M, Janes C, Turner CJ. Cost analysis of a provincial drug program to guide the treatment of upper gastrointestinal disorders. CMAJ 2000; 162:817-23. [PMID: 10750472 PMCID: PMC1231278] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/16/2023] Open
Abstract
BACKGROUND Concerned with the rising costs of its drug programs for seniors and social-assistance recipients, the government of Newfoundland and Labrador requested physicians and pharmacists at the Memorial University of Newfoundland, and members of the Newfoundland and Labrador Medical Association and the Newfoundland Pharmaceutical Association to provide guidance to the health care community for the use of drugs to treat upper gastrointestinal disorders. METHODS Algorithms for the management of dyspepsia and gastrointestinal reflux disease were created and distributed to all physicians and pharmacists in the province in June 1996. On July 1, 1996, the provincial government implemented a program to restrict payment for proton-pump inhibitors through its drug programs to situations defined by the algorithms. Restrictions were not applied to the prescribing of cimetidine, ranitidine and prokinetic agents. The status of famotidine and nizatidine was changed from "open benefit" to "special consideration," which requires prescribers to request authorization of their use on a case-by-case basis. RESULTS Between July 1 and Dec. 31, 1996, 973 of 1078 requests for a proton-pump inhibitor were approved (679 for gastroesophageal reflux, 186 for Helicobacter pylori eradication, 55 for ulcer treatment and 53 for other reasons). The program resulted in a sustained reduction in drug expenditures. Total drug expenditures, which had risen from $39.0 million in 1992/93 to $50.8 million in 1995/96, fell after implementation of the program to $46.4 million in 1996/97 because of a decrease of more than 80% in the use of proton-pump inhibitors. Expenditures on proton-pump inhibitors, which had increased from $0.7 million for the 6 months ending March 1993 to $1.6 million for the 6 months ending March 1996, decreased to $0.3 million for the 6 months ending March 1997. The use of H2-antagonists, but not prokinetic agents, increased concomitantly with the decline in proton-pump inhibitor use. Compared with the year preceding implementation of the program, annual combined expenditures in the subsequent 3 years for H2-antagonists, prokinetic drugs and proton-pump inhibitors were reduced by $1.6 million, $1.7 million and $1.0 million, respectively. Feedback from physicians and pharmacists was supportive for the clinical information and prescribing guidelines. Concerns were mostly limited to process issues. INTERPRETATION The program, designed by health care professionals, approved by health care associations and implemented by the province of Newfoundland and Labrador to guide the treatment of upper gastrointestinal disorders, has achieved a substantial reduction in drug expenditures.
Collapse
Affiliation(s)
- F Bursey
- Department of Medicine (Gastroenterology), Memorial University of Newfoundland, St. John's
| | | | | | | |
Collapse
|
22
|
Bradley CP, Crowley M, Barry C, Stevenson FA, Britten N, Barber N. Patient-centredness and outcomes in primary care. Br J Gen Pract 2000; 50:149. [PMID: 10750218 PMCID: PMC1313638] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/16/2023] Open
|
23
|
Li L, Crowley M, Nguyen A, Lo D. Ability of a nondepleting anti-CD4 antibody to inhibit Th2 responses and allergic lung inflammation is independent of coreceptor function. J Immunol 1999; 163:6557-66. [PMID: 10586049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 02/14/2023]
Abstract
Nondepleting anti-CD4 Abs have been used in vivo to induce Ag-specific immunological tolerance in Th1 responses, including tissue allograft rejection and autoimmune diabetes. To examine whether this Ab (YTS177.9) acts by provoking a Th2 shift, we tested the effect in a mouse model of allergic lung inflammation. Interestingly, nondepleting anti-CD4 treatment induces tolerance to allergens as well, especially when given during initial priming. In vitro studies indicate that the effect of the Ab is independent of CD4 coreceptor function, as Ab treatment also inhibits proliferation and induces a persistent anergy in naive CD4 T cells stimulated by anti-CD3/CD28. Moreover, the Ab stimulated a distinct pattern of tyrosine phosphorylation in T cells even in the absence of TCR triggering, suggesting that signaling through CD4 alone induces significant physiological changes in T cell function. These results show that tolerance induced by anti-CD4 triggering is not a simple shift in Th1/Th2 effector function or depletion of Ag-specific cells, but may instead induce a persistent clonal anergy capable of blocking subsequent immunity.
Collapse
MESH Headings
- Administration, Intranasal
- Animals
- Antibodies, Monoclonal/administration & dosage
- Antibodies, Monoclonal/pharmacology
- CD4 Antigens/immunology
- CD4-Positive T-Lymphocytes/immunology
- CD4-Positive T-Lymphocytes/metabolism
- CD4-Positive T-Lymphocytes/pathology
- Clonal Anergy
- Epitopes, T-Lymphocyte/administration & dosage
- Epitopes, T-Lymphocyte/immunology
- Immunosuppressive Agents/administration & dosage
- Immunosuppressive Agents/pharmacology
- Inflammation/immunology
- Inflammation/prevention & control
- Intracellular Fluid/immunology
- Intracellular Fluid/metabolism
- Lung/immunology
- Lung/pathology
- Lymphocyte Depletion
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Mice, Transgenic
- Ovalbumin/administration & dosage
- Ovalbumin/immunology
- Phosphorylation
- Receptors, Antigen, T-Cell/physiology
- Respiratory Hypersensitivity/immunology
- Respiratory Hypersensitivity/pathology
- Respiratory Hypersensitivity/prevention & control
- Th2 Cells/immunology
- Th2 Cells/metabolism
- Tyrosine/metabolism
Collapse
Affiliation(s)
- L Li
- Department of Immunology IMM-25, The Scripps Research Institute, La Jolla, CA 92037, USA
| | | | | | | |
Collapse
|
24
|
Abstract
The mammalian defense system can respond to a variety of threats, but this capability is not just a simple alarm system for triggering antigen-presenting cells and initiating cellular immunity. Instead, the body is an integrated system in which nearly every cell type can relay the alarm through the production of chemokines, which recruit specific inflammatory cells to the target tissues. This chemokine production is carefully regulated at several levels so that the kinetics and character of local tissue inflammation is tailored to the specific threat. First, the production of nuclear factor-kappa B-regulated chemokines can be modulated in non-bone marrow-derived cells through transcriptional repression mediated by RelB. RelB is also implicated in the differentiation of lymphoid dendritic cells, suggesting that this gene regulates the transition from acute inflammation to adaptive immunity. Second, tissue parenchymal cells, in their capacity as sentinel cells, are able to produce different patterns of chemokines in response to different alarm stimuli. Third, cells from different tissues also show distinct potentials for chemokine responses so that the non-specific damage from inflammation might be avoided in some cases. Finally, the differentiation of T-cell effectors allows for further regulation of local inflammation as their cytokines can also affect chemokine production. This integration of innate and adaptive immunity allows for both rapid responses and dynamic regulation of inflammation in vivo.
Collapse
Affiliation(s)
- D Lo
- Department of Immunology, Scripps Research Institute, La Jolla, California 92037, USA
| | | | | | | | | | | | | | | |
Collapse
|
25
|
|
26
|
O'Leary JJ, Landers RJ, Silva I, Uhlmann V, Crowley M, Healy I, Luttich K. Molecular analysis of ras oncogenes in CIN III and in stage I and II invasive squamous cell carcinoma of the uterine cervix. J Clin Pathol 1998; 51:576-82. [PMID: 9828814 PMCID: PMC500848 DOI: 10.1136/jcp.51.8.576] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
AIM To examine the prevalence of genital type human papilloma virus (HPV) and mutations at codons 12, 13, and 61 in H, Ki, and N-ras in CIN III and early invasive squamous cell carcinomas of the cervix. METHODS Prevalence of HPV was examined in 20 CIN III and 20 stage I and II cervical carcinomas, using non-isotopic in situ hybridisation (NISH) and solution phase polymerase chain reaction (PCR). In addition, mutations at codons 12, 13, and 61 were examined in H, Ki, and N-ras in these CIN III and early invasive squamous cell carcinomas, to assess the prevalence of ras gene point mutations and to define where in the pathobiology of squamous cell carcinoma such events occur. A non-isotopic PCR/RFLP assay was used to define these mutations. RESULTS Of the 20 CIN IIIs examined, 19 contained HPV 16 DNA sequences by PCR and NISH. Dual infection was not uncovered. The 20 early (stage I and II) invasive squamous cell carcinomas showed predominant HPV 16 positivity (17/20), with one case HPV 18 positive, confirmed on PCR and NISH. Activating mutations were not identified in any of the CIN III cases. Only one stage I, HPV 16 positive carcinoma showed an activating mutation in H-ras codon 12, which was not present in adjacent normal ectocervical mucosa from the same patient. CONCLUSIONS ras Activation does not appear to occur in conjunction with HPV infection, particularly of HPV 16 infected high grade cervical intraepithelial neoplasia, or to occur commonly in early cervical squamous cell carcinoma. The postulated model of HPV linked carcinogenesis suggests malfunctional control of viral transcription as a necessary component of neoplastic progression. It is also clear that host gene alterations are equally necessary for HPV linked carcinogenesis to occur.
Collapse
Affiliation(s)
- J J O'Leary
- Department of Pathology, Cornell University Medical College, New York, USA
| | | | | | | | | | | | | |
Collapse
|
27
|
Abstract
Strong epidemiological evidence links human papilloma viruses (HPV) with the development of cervical intraepithelial neoplasia (CIN) and invasive cancers of the uterine cervix. The localization of HPV DNA sequences high up in the female genital tract (in benign and malignant lesions) is not that uncommon, but its precise significance is uncertain. In particular, the detection of HPV DNA sequences by polymerase chain reaction (PCR) needs careful interpretation, because the source of the amplicon may emanate from tumor cells, direct contamination from the cervix, or possibly from extratumoral sites in the endometrium. We have previously reported the identification of koilocyte-like changes in the squamous epithelium of some endometrial adenoacanthomas. Adenoacanthomas (adenocarcinoma with squamous metaplasia) are mixed epithelial tumors arising in the endometrium composed of malignant glandular areas admixed with benign metaplastic squamous epithelium. The rarer adenosquamous carcinoma containing both malignant glandular and squamous areas is also described. The origin of benign/malignant squamous epithelial islands in endometrial tumors has been the subject of speculation, with some investigators considering an origin from metaplastic glandular endometrial cells. In this study, we examined 10 normal endometrial samples, 20 adenocarcinomas, 41 adenocarcinomas with squamous metaplasia, and two adenosquamous carcinomas, (including control cervical material where possible) for the presence of HPV DNA sequences using nonisotopic in situ hybridization (NISH), type-specific HPV PCR, general primer PCR (to detect sequenced and unsequenced HPVs), and PCR in situ hybridization (PCR-ISH). We did not identify HPV DNA sequences in normal endometrial tissue. In adenocarcinomas (endometrioid type), HPV was only identified in 2 of 20 cases by PCR, both of which were HPV 11 positive. We were unsuccessful in identifying HPV in endometrial carcinomas by NISH or by PCR-ISH, raising the possibility of contamination from the cervix in the two positive cases. In adenoacanthomas, a low-risk HPV type (HPV 6) was found in 19 of 41 cases. NISH signals were intranuclear in location in squamous regions of adenoacanthomas. Additional positive nuclei were uncovered using PCR-ISH, which increases the sensitivity of standard NISH detection. HPV DNA sequences were located in some malignant endometrial glandular epithelial cells, but this accounted for a minority of samples. HPV DNA sequences were not detected in extraepithelial sites. Mixed infection by two different HPV types was identified in two cases. Most cases showed similar HPV types in cervical and endometrial lesions, although discordant cases were uncovered. In adenosquamous carcinomas, one case showed mixed infection with HPV 6 and 33 by PCR. The apparent segregation of low-risk HPV type (HPV 6) with benign squamous metaplastic epithelium in adenocarcinoma with squamous metaplasia, and high-risk type (HPV 33) with malignant squamous epithelium in adenosquamous carcinoma, raises important questions in relation to the role of HPVs in mixed epithelial tumors of the endometrium and their interplay in the pathogenesis of squamous metaplasia at extracervical sites.
Collapse
Affiliation(s)
- J J O'Leary
- Nuffield Department of Pathology and Bacteriology, University of Oxford, United Kingdom
| | | | | | | | | | | | | | | | | |
Collapse
|
28
|
O'Leary JJ, Landers RJ, Crowley M, Healy I, Kealy WF, Hogan J, Doyle CT. Alterations in exon 1 of c-myc and expression of p62c-myc in cervical squamous cell carcinoma. J Clin Pathol 1997; 50:896-903. [PMID: 9462237 PMCID: PMC500312 DOI: 10.1136/jcp.50.11.896] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
AIMS To examine human papillomavirus (HPV) positive and negative squamous cell carcinomas of the cervix for structural alterations in exon 1 c-myc; and to investigate the expression pattern of p62, the protein product of c-myc. MATERIAL Archival paraffin wax embedded tissues of cervical squamous cell carcinomas, stage I and II, retrieved from the files of the department of pathology, University College Cork, Ireland: 40 cases were examined for alterations in exon 1 of c-myc; 57 cases were used for immunocytochemical p62 analysis. METHODS c-myc exon 1 PCR on HPV positive and negative stage I and II cervical squamous cell carcinomas was performed using primers designed to fragile sites in exon 1 of the c-myc oncogene, which are frequently involved in translocation phenomena and deletions in other neoplasms. This region is bordered by two promoter sequences P1 and P2. In addition, the expression of p62 was evaluated using the monoclonal antibody Mycl-9E10. RESULTS Alterations in exon 1 of c-myc were shown in 7.5% of squamous cell carcinomas of the cervix. Changes in exon 1 and 2 of c-myc were also found in COLO 320 cells and Raji cells. These alterations were due to small deletions within exon 1 of c-myc, but point polymorphisms occurring within the priming sites (in one case) may also have occurred. The alterations uncovered appeared "clonal," as replicate samples showed the same amplicon band pattern. Expression of c-myc was variable, with cytoplasmic staining patterns predominating. All cases which showed exon 1 alterations were HPV positive and had strong nuclear positivity on p62 immunocytochemistry. CONCLUSIONS Alterations in exon 1 of c-myc occur in a minority of cervical cancers and there was increased expression of p62 in a cohort of HPV positive and negative cervical squamous cell carcinomas. Exon 1 alterations may provide an alternative route to c-myc activation in early squamous cell carcinoma.
Collapse
Affiliation(s)
- J J O'Leary
- Nuffield Department of Pathology and Bacteriology, University of Oxford, UK.
| | | | | | | | | | | | | |
Collapse
|
29
|
O'Leary JJ, Landers RJ, Crowley M, Healy I, Kealy WF, Hogan J, Cullinane C, Kelehan P, Doyle CT. Genotypic mapping of HPV and assessment of EBV prevalence in endocervical lesions. J Clin Pathol 1997; 50:904-10. [PMID: 9462238 PMCID: PMC500313 DOI: 10.1136/jcp.50.11.904] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
AIMS To examine the prevalence of human papillomavirus (HPV) and Epstein-Barr virus (EBV) in low grade glandular intraepithelial lesions of the cervix, adenocarcinoma with high grade glandular intraepithelial lesions combined, and adenocarcinomas; and to perform a genotyping mapping analysis of endocervical carcinomas to determine the extent of HPV infections in such lesions. MATERIAL Archival paraffin wax embeded material from the files of the departments of pathology, National Maternity Hospital, Dublin, and University College Cork, Ireland. METHODS HPV prevalence was examined using type specific HPV PCR, general primer HPV PCR (pan HPV screen), nonisotopic in situ hybridisation (NISH), and PCR in situ hybridisation (PCR-ISH). In situ hybridisation was performed using fluorescein labelled oligonucleotide cocktail for eber transcripts of EBV. Genotypic analysis was performed, in all cases where possible, using a grid system. RESULTS HPV 16 and 18 were predominantly identified in low grade glandular intraepithelial lesions, high grade glandular intraepithelial lesions, and adenocarcinomas, with HPV prevalence increasing with grade of dysplasia. EBV was only identified in subepithelial lymphocytes in a minority of cases. No link could be shown between HPV and EBV in endocervical lesions. HPV infection was not clonal in endocervical cancer and coexistent adjacent cervical intraepithelial neoplasia, where present, tended to show a similar HPV type. CONCLUSIONS The restriction of HPV types 16 and 18 to endocervical lesions suggests that their effect is restricted and specific to endocervical mucosa, but the mechanism of interaction is currently unknown.
Collapse
Affiliation(s)
- J J O'Leary
- Nuffield Department of Pathology and Bacteriology, University of Oxford, UK
| | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Abstract
This study examined barriers that families experience during treatment and the role these barriers play in participation and completion of therapy. We developed the Barriers to Treatment Participation Scale and evaluated performance among children (N = 260, ages 3-13) and families referred for outpatient treatment. The results indicated that: (a) the scale yielded high levels of internal consistency; (b) the experience of barriers to participation, whether rated by parents or therapists, predicted higher rates of dropping out of treatment, fewer weeks in treatment, and higher rates of cancelled appointments and not showing up for sessions; (c) the perception of barriers was distinguishable from several family, parent, and child characteristics assessed at intake and the experience of critical life events during treatment; and (d) perceived barriers added significant information in predicting participation in treatment, over and above other characteristics that are already known to predict poor participation in treatment. Barriers associated with treatment participation can help identify cases at risk for dropping out and suggest targets for intervention to improve retention of families in treatment.
Collapse
Affiliation(s)
- A E Kazdin
- Department of Psychology, Yale University, New Haven, CT 06520-8205, USA
| | | | | | | |
Collapse
|
31
|
Duan Y, Wilkosz P, Crowley M, Rosenberg JM. Molecular dynamics simulation study of DNA dodecamer d(CGCGAATTCGCG) in solution: conformation and hydration. J Mol Biol 1997; 272:553-72. [PMID: 9325112 DOI: 10.1006/jmbi.1997.1247] [Citation(s) in RCA: 93] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
A molecular dynamics simulation of the dodecamer duplex d(CGCGAATTCGCG) using the particle mesh Ewald sum assumed a B-conformation remarkably close to the observed X-ray structure. The Ewald summation method effectively eliminates the usual "cut-off" of long-range interactions and allowed us to evaluate the full effect of the electrostatic forces. This simulation showed remarkable agreement with the Dickerson X-ray structure in both average structure and B-factors; within the EcoRI site itself, the rms deviation between the average theoretical and observed structures was 1.1 A. The width of the minor groove fluctuated between a wide and narrow configuration with the latter corresponding closely to the X-ray structure. The simulation also suggested a strong sequence-dependent signature on the minor groove width in both wide and narrow conformers. Hydration shells in both the major and minor grooves were observed. The "spine of hydration" in the minor groove was clear. In the major groove the first hydration shell appears to be a ribbon-like structure that reproduces the principal features of observed X-ray structures; subtle variations of this hydration pattern suggest sequence dependencies. Sequence-dependent features were also examined for helical and other geometric parameters. The successful reproduction of many experimentally observed fine structural features shows that the Ewald summation significantly improves the fidelity of the calculations.
Collapse
Affiliation(s)
- Y Duan
- Department of Biological Sciences and W. M. Keck Center for Advanced Training in Computational Biology Sciences, University of Pittsburgh, Pittsburgh, PA 15260, USA
| | | | | | | |
Collapse
|
32
|
Abstract
Barriers to participation in treatment were proposed as a basis for dropping out of treatment among children seen in outpatient therapy. Families (N = 242) of children referred for treatment for oppositional, aggressive, and antisocial behavior participated. The main findings were that (a) barriers to participation in treatment contributed significantly to dropping out of therapy; (b) perceived barriers to treatment were not explained by family, parent, and child characteristics that also predicted dropping out; and (c) among families at high risk for dropping out of treatment, the perception of few barriers attenuated risk. Parent perceptions of the difficulties of participating in treatment (including stressors and obstacles associated with treatment, perceptions that treatment is not very relevant, and a poor relationship with the therapist) influenced who dropped out.
Collapse
Affiliation(s)
- A E Kazdin
- Department of Psychology, Yale University, New Haven, Connecticut 06520-8205, USA
| | | | | |
Collapse
|
33
|
Abstract
Barriers to participation in treatment were proposed as a basis for dropping out of treatment among children seen in outpatient therapy. Families (N = 242) of children referred for treatment for oppositional, aggressive, and antisocial behavior participated. The main findings were that (a) barriers to participation in treatment contributed significantly to dropping out of therapy; (b) perceived barriers to treatment were not explained by family, parent, and child characteristics that also predicted dropping out; and (c) among families at high risk for dropping out of treatment, the perception of few barriers attenuated risk. Parent perceptions of the difficulties of participating in treatment (including stressors and obstacles associated with treatment, perceptions that treatment is not very relevant, and a poor relationship with the therapist) influenced who dropped out.
Collapse
Affiliation(s)
- A E Kazdin
- Department of Psychology, Yale University, New Haven, Connecticut 06520-8205, USA
| | | | | |
Collapse
|
34
|
Crowley M. Exercise restores seniors' strength and spirits. Fitness plans keep residents of retirement community independent and socially active. Health Prog 1996; 77:42-4. [PMID: 10163235] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/12/2023]
Abstract
Statistics, an independent study, and anecdotal reports are documenting the health benefits of regular exercise for older adults living at the McAuley Center, a continuing care retirement community in West Hartford, CT. As part of its commitment to holistic health, the center links residents with an on-site fitness counselor, who develops an individualized exercise program and helps motivate residents to stick with it. Residents can choose from individual personal training or rehabilitation programs or group programs such as aerobics or line dancing. The results speak for themselves. For the past five years, only 0.05 percent of the falls at the McAuley Center occurred among the 21 percent of the residents who exercise regularly. In addition, residents and staff alike report increased social interactions among those who exercise. Overall, residents and staff say the benefits of regular exercise contribute significantly to the goal of independent living at the McAuley Center.
Collapse
Affiliation(s)
- M Crowley
- Continuum Learning, Ltd., Gresham, OR, USA
| |
Collapse
|
35
|
Abstract
To assess the impact of sumatriptan in clinical practice, we undertook a retrospective analysis of the government of Newfoundland and Labrador's prescription drug program data base for 35 consecutive patients prescribed sumatriptan. The number of doses of all drugs prescribed ranged from 121 to 18,874 on from 4 to 357 prescriptions per patient over 1 to 19 months. The mean number of doses of analgesic drugs prescribed before sumatriptan therapy was 56 per month and after initiation of sumatriptan was 46 per month. The prescribing of multiple analgesics was common; 79% received three or more different analgesics. Twenty-two (63%) patients were prescribed medications indicated for the prophylaxis of migraine concomitantly with drugs indicated for symptomatic treatment. Twenty-four (69%) patients were prescribed medication capable of inducing migraine. We conclude that sumatriptan did not have a major impact on the outcomes of these patients judged by their use of analgesics. The simplest explanation is that many of the patients were suffering from analgesic-induced headache rather than migraine. In addition, we conclude that there were deficiencies in prescribing practices including numbers, quantities, and choice of analgesics; the use of analgesics concomitantly with drugs indicated for migraine prophylaxis; and the use of drugs capable of inducing migraine. Further research is required to validate these findings.
Collapse
Affiliation(s)
- S Furlong
- Memorial University of Newfoundland, St John's, Canada
| | | | | | | |
Collapse
|
36
|
Sullivan PA, Crowley M, Grosch C. Blood pressure and heart rate dynamics during and after exercise in an unselected population. Ir J Med Sci 1996; 165:250-3. [PMID: 8990647 DOI: 10.1007/bf02943082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
It has been suggested that the systolic blood pressure (SBP) response to exercise may be useful in predicting future hypertension. However, controversy exists as to whether the SBP response to exercise in borderline hypertensives is actually greater than normotensives or merely increases equally but from a higher resting value. Our aim was to determine the influence of resting SBP, age and sex on changes of SSP during exercise for both healthy subjects and untreated mild hypertensives. Three hundred and eighteen (230 males) underwent a self limited exercise protocol. SBP was measured at baseline and between the 2nd and 3rd minutes of each exercise stage. Age was positively related to SBP at rest and during exercise. The magnitude of SBP change induced by exercise was similar irrespective of the level of resting SBP. The relationship between resting SBP and the absolute SBP change which occurred during exercise was independent of sex. Our findings indicate that (i) age is positively related to SBP at rest and during exercise, (ii) SBP rises equally during exercise irrespective of its resting level and (iii) males and females have a similar pattern of BP response to exercise.
Collapse
|
37
|
O'Brien MG, Fitzgerald EF, Lee G, Crowley M, Shanahan F, O'Sullivan GC. A prospective comparison of laparoscopy and imaging in the staging of esophagogastric cancer before surgery. Am J Gastroenterol 1995; 90:2191-4. [PMID: 8540514] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
OBJECTIVE To carry out a prospective comparison of laparoscopy and combined imaging (CT and ultrasound) in the preoperative staging of distal esophageal and gastric cancer in patients who were selected for surgery. METHODS Patients with clinically overt metastases or a contraindication to major surgery were excluded. One hundred and forty-five patients underwent chest radiography, CT of mediastinum and abdomen, and ultrasonography of abdomen and laparoscopy. The primary diagnoses were adenocarcinoma of the esophagogastric region in 110 cases, squamous cell carcinoma of the distal esophagus in 30 patients, and five miscellaneous. RESULTS Thirty nine (27%) patients had metastatic disease outside the potential field of resection. Metastases were detected preoperatively by laparoscopy in 30 patients (sensitivity 77%) and by combined imaging in 15 (sensitivity 38%) (p < 0.01). Twenty four patients with adenocarcinoma had metastases to the peritoneal cavity, which were detected preoperatively by laparoscopy in 23 (sensitivity 96%) and by combined imaging in five (sensitivity 21%) (p < 0.01). Peritoneal metastases were not seen in patients with squamous cell carcinoma. Fifteen patients had hepatic metastases, which were detected preoperatively by laparoscopy in nine (sensitivity 60%) and by combined imaging in seven (sensitivity 47%). Laparoscopy was more sensitive than combined imaging in detecting metastases in patients with adenocarcinoma [laparoscopy 28, combined imaging 10 (p < 0.01)]. CONCLUSION Addition of laparoscopy to the staging protocol prevented unbeneficial thoraco-abdominal exploration in 20 patients with adenocarcinoma. Thus, laparoscopy should be used in the assessment of patients with adenocarcinoma of the esophagogastric region before performing excisional surgery.
Collapse
Affiliation(s)
- M G O'Brien
- Department of Surgery, Mercy Hospital, Cork, Ireland
| | | | | | | | | | | |
Collapse
|
38
|
Healy M, O’Moore R, Keane EM, Coakley D, Walsh JB, Tully M, Swanwick G, Coen R, Bruce I, O’Mahony D, Radic A, O’Kelly F, O’Doherty M, Lawlor BA, Lee H, Conway J, Keane E, Ng K, Murphy S, Khaw KT, May H, Compston JE, Taggart H, Crawford V, Twomey C, Delaney L, Crowley M, Hyland M, Hegarty V, Donovan MC, Pye M, Reardon M, Coleman P, Hyland CM, Scott T, Keane CT, Farragher B, O’Connor A, Quinn E, Mahony D, Rowan M, Buggy F, Freyne A, Wrigley M, Passmore AP, Crawford VLS, Beringer TRO, Gilmore DH, Hussain A, Grant D, Montgomery A, Hemeryck L, McCormack PME, Sheehan N, Guely A, Leonard L, Caulfield D, Nic Cártaigh M, Feely J, Mulkerrin E, Clark BA, Epstein FH, Keane N, McCabe E, Shepherd M, O’Donnell MJ, Cooper RA, Nurzaman M, Brooks RW, Sinha SK, Kane D, McKiernan M, Crowe J, Lennon J, Sheehan J, Rearden M, Hyland M, Tracey F, Lawson JT, Stout RW, Williams H, Naguib M, O’Keefe S, Lavan J, Madigan SM, McNulty H, Eaton-Evans J, Strain JJ, Stanwick G, Horgan F, Keating D, Crowe M, McNamara A, Leahy P, Healy S, Moraes D, Tyrell J, Crawford VLS, O’Keeffe S, Glasgow R, Tormey W, Finucane P, Nair BK, McCann C, Coen RF, O’Boyle CA, Joyce CRB, Hiltbrunner B, Clarke R, Cooney J. Irish Gerontological Society. Ir J Med Sci 1994. [DOI: 10.1007/bf02940568] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
39
|
O'Leary JJ, Browne G, Johnson MI, Landers RJ, Crowley M, Healy I, Street JT, Pollock AM, Lewis FA, Andrew A. PCR in situ hybridisation detection of HPV 16 in fixed CaSki and fixed SiHa cell lines. J Clin Pathol 1994; 47:933-8. [PMID: 7962608 PMCID: PMC502179 DOI: 10.1136/jcp.47.10.933] [Citation(s) in RCA: 26] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
AIMS To investigate the feasibility of using fixed cells with the polymerase chain reaction (PCR) in situ hybridisation and to investigate possible reasons for reaction failure. METHODS Fixed SiHa and CaSki cells were used in an experimental model of PCR in situ hybridisation for the detection of low and intermediate copy number viral infection in fixed cells. RESULTS PCR in situ hybridisation was able to detect one to two copies of human papillomavirus (HPV) 16 in SiHa cells, using small fragment amplicons (120 base pairs), confirming the high detection sensitivity and flexibility of the technique. Problems were encountered with localisation of PCR amplified product in CaSki cells (200-300 copies of HPV 16 per cell) owing to diffusion of product post amplification. Overall, 40% of reactions were successful, which confirms the current unreliability of the technique. Within cell preparations, about 50% of cells contained amplified product. CONCLUSION PCR in situ hybridisation represents the marriage of two revolutionary molecular pathological techniques. However, it is currently unreliable, with reaction failure common. Standardised, dedicated equipment is urgently required if the technique is to achieve universal acceptance. In the future, the technique may be used to detect chromosomal translocations in human tumours and to study cellular gene expression.
Collapse
Affiliation(s)
- J J O'Leary
- Nuffield Department of Pathology and Bacteriology, University of Oxford
| | | | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Murphy KM, O’Brien F, Madden M, Collins JK, Lee G, Fitzgerald E, Crowley M, Morgan J, Shanahan F, O’Sullivan G, Khan MI, Cherukuri AK, Farrell RJ, Farrell J, Quinn P, Noonan N, Kanduru C, Keeling PWN, Keely SJ, Stack WA, Skelly MM, Stack M, O’Donoghue DP, Baird AW, Barry MC, Condron C, Watson RWG, Redmond HP, Watson RGK, Bouchier-Hayes D, McManus R, Moloney M, Borton M, Chuan YT, Finch A, Weir DG, Kelleher D, Watson RGP, McMillan SA, McMaster D, Evans A, Merriman R, MacMathuna P, Frazier I, Crowe J, Lennon J, Fan XG, Fan XJ, Xia H, Madrigal L, Feighery C, O’Donoghue D, Whelan CA, O’Farrelly C, Crowley MJ, O’Leary P, Devereux C, White P, Clarke E, Norris S, Crosbie O, Traynor O, McEntee G, Hegarty J, Marshall SG, Spence RAJ, Parks TG, Barrett J, O’Brien M, Sullivan GCO, Walsh TN, Mealy K, Hennessey TPJ, Donnelly VS, O’Herlihy C, O’Connell PR, Morrissey D, Lynch D, Caldwell MTP, Byrne PJ, Marks P, Hennessy TPJ, Maguire D, Harvey B, Wang JH, Mahmud N, McDonald GSA, Windle HJ, Neary P, Reid S, Horgan P, Hyland J, Graham D, Yeoh PL, Kelly P, Gibbons D, Mulcahy H, McCarthy P, Duffy MJ, Parfrey NA, Sheahan K, Husain A, O’Suilleabhain CB, Waldron D, Kelly J, O’Riordain M, Kirwan WO, Parks RW, Spencer EFA, Mcllrath EM, Johnson GW, Carton J, Lynch S. Irish society of gastroenterology. Ir J Med Sci 1994. [DOI: 10.1007/bf02942130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
41
|
O'Leary JJ, Browne G, Landers RJ, Crowley M, Healy IB, Street JT, Pollock AM, Murphy J, Johnson MI, Lewis FA. The importance of fixation procedures on DNA template and its suitability for solution-phase polymerase chain reaction and PCR in situ hybridization. Histochem J 1994; 26:337-46. [PMID: 8040006 DOI: 10.1007/bf00157767] [Citation(s) in RCA: 50] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
Conventional solution-phase polymerase chain reaction (PCR) and in situ PCR/PCR in situ hybridization are powerful tools for retrospective analysis of fixed paraffin wax-embedded material. Amplification failure using these techniques is now encountered in some centres using archival fixed tissues. Such 'failures' may not only be due to absent target DNA sequences in the tissues, but may be a direct effect of the type of fixative, fixation time and/or fixation temperature used. The type of nucleic acid extraction procedure applied will also influence amplification results. This is particularly true with in situ PCR/PCR in situ hybridization. To examine these effects in solution-phase PCR, beta-globin gene was amplified in 100 mg pieces of tonsillar tissue fixed in Formal saline, 10% formalin, neutral buffered formaldehyde, Carnoy's Bouin's, buffered formaldehyde sublimate, Zenker's, Helly's and glutaraldehyde at 0 to 4 degrees C, room temperature and 37 degrees C fixation temperatures and for fixation periods of 6, 24, 48 and 72 hours and 1 week. DNA extraction procedures used were simple boiling and 5 days' proteinase K digestion at 37 degrees C. Amplified product was visible primarily yet variably from tissue fixed in neutral buffered formaldehyde and Carnoy's, whereas fixation in mercuric chloride-based fixatives produced consistently negative results. Room temperature and 37 degrees C fixation temperature appeared most conducive to yielding amplifiable DNA template. Fixation times of 24 and 48 hours in neutral buffered formaldehyde and Carnoy's again favoured amplification.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- J J O'Leary
- Department of Pathology, University of Leeds, UK
| | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
O'Leary J, Browne G, Landers R, Crowley M, Healy I, Johnson M, Doyle C. New nucleic acid amplification techniques in diagnostic pathology. J Eur Acad Dermatol Venereol 1994. [DOI: 10.1111/j.1468-3083.1994.tb00077.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
43
|
Landers RJ, O'Leary JJ, Crowley M, Healy I, Annis P, Burke L, O'Brien D, Hogan J, Kealy WF, Lewis FA. Epstein-Barr virus in normal, pre-malignant, and malignant lesions of the uterine cervix. J Clin Pathol 1993; 46:931-5. [PMID: 8227411 PMCID: PMC501621 DOI: 10.1136/jcp.46.10.931] [Citation(s) in RCA: 51] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
AIM--To detect the presence or absence of Epstein-Barr virus (EBV) in cervical lesions ranging from normality to invasive malignancy. METHODS--Eighteen randomly selected cases of invasive squamous cell carcinomas of the uterine cervix were examined as well as 25 cases each of normal cervices and those showing cervical intra-epithelial neoplasia (CIN) I, II, and III. DNA-DNA in situ hybridisation, using a biotinylated probe to the Bam H1 "W" fragment of EBV, was carried out in addition to the polymerase chain reaction using specific primer sequences that flank a 153 base pair segment of the Bam H1 "W" region of the EBV genome and which do not cross-amplify other DNA herpes viruses. Positive control material included paraffin wax embedded P3 HR1 lymphoblastoid cells (containing high copy numbers of EBV) and two nasopharyngeal carcinomas positive for EBV. RESULTS--Neither normal nor CIN I tissue was positive. Eight per cent of CIN II tissue was positive; 8% of CIN III, and 43% of carcinomas were positive for EBV. CONCLUSION--The study shows that the virus is present in some cases of cervical carcinoma and to a lesser degree in some premalignant lesions of the cervix, but the exact association between it and cervical oncogenesis, be it causative or incidental, remains to be determined.
Collapse
Affiliation(s)
- R J Landers
- Department of Pathology, University College Cork, Ireland
| | | | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Crowley M. Witness. Interview by Daloni Carlisle. Nurs Times 1993; 89:46-7. [PMID: 8516148] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
|
45
|
Abstract
Age standardised oral cancer incidence rates were calculated for the Republic of Ireland from data collected by the Southern Tumour Registry for the years 1984-1988. The annual incidence rates (per 100,000) for men were lip 3.8, tongue 1.2 and mouth 1.8 while the corresponding rates for women were lip 0.2, tongue 0.7 and mouth 0.5. The incidence of lip cancer is shown to be much lower than indicated by previously published Irish rates. In general, oral cancer incidence rates in Ireland are comparable to those reported for Denmark. The vast majority (94%) of cases were histologically verified. The results, along with recent findings on mortality, contradict the view that Ireland has a very high rate of oral cancer by west European standards.
Collapse
Affiliation(s)
- B E McCartan
- Department of Oral Surgery, Oral Medicine and Oral Pathology, School of Dental Science, Trinity College, Ireland
| | | |
Collapse
|
46
|
Walsh PN, Conliffe C, Abdulkadir AS, Kelehan P, Conroy R, Foley M, Lenehan P, Murphy JF, Stronge J, Cantwell B, Wright C, Millward M, Carpenter M, Lennard T, Wilson R, Home C, Corbett AR, O’Sullivan G, Collins JK, Doran M, McDermott EWM, Mercer P, Smyth P, O’Higgins NJ, Duffy MJ, Reilly D, McDermott E, Faul C, Fennelly JJ, O’Higgins N, Lowry S, Russell H, Atkinson R, Hickey I, O’Brien F, O’Mahony A, O’Donoghue M, Pomeroy M, Prosser ES, Barker F, Casey M, Carroll K, Davis M, Duffy G, O’Kennedy R, Smyth PPA, O’Carroll D, Hetherton AM, Coveney E, McAlister V, Murray MJ, Brayden DJ, O’Hora A, Street J, O’Leary J, Pollock AM, Crowley M, Healy I, Murphy J, Landers R, Burke L, O’Brien D, Annis P, Hogan J, Kealy W, Lewis FA, Doyle CT, Callaghan M, Whelan A, Feighery C, Bresnihan B, Kelleher D, Reams G, Murphy A, Hall N, Casey EB, Mulherin D, Doherty E, Yanni G, Wallace E, Jackson J, Bennett M, Tighe O, Mulcahy H, O’Donoghue D, Croke DT, Cahill RJ, Beattie S, Hamilton H, O’Morain C, Corridan B, Collins RA, O’Morain CA, Fitzgerald E, Gilvarry JM, Leader M, Fielding JF, Johnson BT, Lewis SA, Love AHG, Johnston BT, Collins JSA, McFarland RJ, Johnston PW, Collins BJ, Kilgallen CM, Murphy GM, Markey GM, McCormack JA, Curry RC, Morris TCM, Alexander HD, Edgar S, Treacy M, O’Connell MA, Weir DG, Sheehan J, O’Loughlin G, Traynor O, Walsh N, Xia HX, Daw MA, Keane CT, Dupont C, Gibson G, McGinnity E, Walshe J, Carmody M, Donohoe J, McGrath P, O’Moore R, Kieran E, Rogers S, McKenna KE, Walsh M, Bingham EA, Hughes AE, Nevin NC, Todd DJ, Stanford CF, Callender ME, Burrows D, Paige DG, Allen GE, O’Brien DP, Gough DB, Phelan C, Given HF, Kamal SZ, Kehoe S, Coldicott S, Luesley D, Ward K, MacDonnell HF, Mullins S, Gordon I, Norris LA, Devitt M, Bonnar J, Sharma SC, Sheppard BL, Fitzsimons R, Kingston S, Garvey M, Hoey HMCV, Glasgow JFT, Moore R, Robinson PH, Murphy E, Murphy JFA, Wood AE, Sweeney P, Neligan M, MacLeod D, Cunnane G, Kelly P, Corcoran P, Clancy L, Drury RM, Drury MI, Powell D, Firth RGR, Jones T, Ferris BF, O’Flynn W, O’Donnell J, Kingston SM, Cunningham F, Hinds GME, McCluskey DR, Howell F, O’Mahony M, Devlin J, O’Reilly O, Buttanshaw C, Jennings S, Keane ER, Foley-Nolan C, Ryan FM, Taylor M, Lyons RA, O’Kelly F, Mason J, Carroll D, Doherty K, Flynn M, O’Dwyer R, Gilmartin JJ, McCarthy CF, Armstrong C, Mannion D, Feely T, Fitzpatrick G, Cooney CM, Aleong JC, Rooney R, Lyons J, Phelan DM, Joshi GP, McCarroll SM, Blunnie WP, O’Brien TM, Moriarty DC, Brangan J, Kelly CP, Kenny P, Gallagher H, McGovern E, Luke D, Lowe D, Rice T, Phelan D, Lyons JB, Lyons FM, McCoy DM, McGinley J, Hurley J, McDonagh P, Crowley JJ, Donnelly SM, Tobin M, Fitzgerald O, Maurer BJ, Quigley PJ, King G, Duly EB, Trinick TR, Boyle D, Wisdom GB, Geoghegan F, Collins PB, Goss C, Younger K, Mathias P, Graham I, MacGowan SW, Sidhu P, McEneaney DJ, Cochrane DJ, Adgey AAJ, Anderson JM, Moriarty J, Fahy C, Lavender A, Lynch L, McGovern C, Nugent AM, Neely D, Young I, McDowell I, O’Kane M, Nicholls DP, McEneaney D, Nichols DP, Campbell NPS, Campbell GC, Halliday MI, O’Donnell AF, Lonergan M, Ahearne T, O’Neill J, Keaveny TV, Ramsbottom D, Boucher-Hayes D, Sheahan R, Garadaha MT, Kidney D, Freyne P, Gearty G, Crean P, Singh HP, Hargrove M, Subareddy K, Hurley JP, O’Rourke W, O’Connor C, FitzGerald MX, McDonnell TJ, Chan R, Stinson J, Hemeryck L, Feely J, Chopra MP, Sivner A, Sadiq SM, Abernathy E, Plant L, Bredin CP, Hickey P, Slevin G, McCrory K, Long M, Conlon P, Walker F, Fitzgerald P, O’Neill SJ, O’Connor CM, Quigley C, Donnelly S, Southey A, Healy E, Mulcahy F, Lyons DJ, Keating J, O’Mahony C, Roy D, Shattock AG, Hillary IB, Waiz A, Hossain R, Chakraborthy B, Clancy LP, O’Reilly L, Byrne C, Costello E, O’Shaughnessy E, Cryan B, Farrell J, Walshe JJ, Mellotte GJ, Ho CA, Morgan SH, Bending MR, Bonner J. Inaugural national scientific medical meeting. Ir J Med Sci 1993. [PMCID: PMC7101915 DOI: 10.1007/bf02942100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
47
|
Abstract
The role of smoking as a risk factor for periodontitis was assessed separately in diabetic and nondiabetic study groups. Subject listings stratified for age (19 to 40 years) and sex were obtained for subjects with insulin-dependent diabetes mellitus (IDDM) and nondiabetic subjects. For both the IDDM group (n = 132) and the nondiabetic group (n = 95), age and sex stratified samples were constructed by random selection of subjects from each subject listing. Patients were recruited by phone, examined, and their medical and dental histories obtained. Among nondiabetic subjects, the prevalence of periodontitis was markedly higher among current smokers compared with never smokers (P < or = 0.005) in both the 19 to 30 year-old (46% vs. 12%) and 31 to 40 year-old groups (88% vs. 33%). The subject mean percent of sites with gingival pocket depth > or = 4 mm was higher among current smokers than never smokers (P = 0.001) in the 19 to 30 (8.2% vs. 3.4%) and 31 to 40 (14.3% vs. 4.3%) age groups. The effects of smoking among IDDM subjects were similar to that observed in the nondiabetic population. There were no differences between current and never smokers in the proportion of sites positive for plaque. Attributable risk percents from prevalence data suggest that among nondiabetic subjects, a large proportion, perhaps as much as 51% of the periodontitis in the 19 to 30 year old group and 32% of the periodontitis in the 31 to 40 year old group, is associated with smoking.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- J Haber
- Department of Oral Pathology, School of Dental Medicine, Tufts University, Boston, MA
| | | | | | | | | | | |
Collapse
|
48
|
Abstract
Magnetic resonance (MR) may be used for repeatedly and non-invasively imaging the brain. Until now, no studies have used this approach to study the effects of carbon monoxide (CO) poisoning in a defined animal model. Conscious, Levine-prepared female rats (unilateral carotid artery and jugular vein occlusion) were exposed to 2400 ppm CO for 90 min, with or without the infusion of 50% glucose solution; CO-stimulated increases in blood glucose and lactate occurred in both groups, while blood pressure and body temperature fell. One to four hours following termination of CO exposure, increased cortical pixel intensity, cortical surface area and brain midline shift were observed on the operated side of the brain in some rats of both groups (i.e. responders = R), providing evidence of edema. At sacrifice, 5 h following termination of CO exposure, gross water content was increased on the left side in the corresponding cortical slices in R rats, providing another measure of edema. Significant positive correlations were found between left to right pixel intensity difference and water content difference, and between the extent of midline shift and water content difference. The elevations of blood glucose and lactate concentrations, and the magnitudes of CO-induced hypothermia and hypotension were similar to those in past studies, but appeared to exert no effect on the severity of cortical edema in terms of differences in pixel intensity, surface area, midline shift or gross tissue water content. Thus, the observed differences between the R rats is not explained by the available data.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- V Jalukar
- Department of Physiology, Wayne State University School of Medicine, Detroit, MI 48201
| | | | | | | |
Collapse
|
49
|
Crowley M. Living longer and better than expected. A wellness-based model keeps CCRC residents active, healthy, and out of nursing homes. Health Prog 1992; 73:38-41. [PMID: 10122524] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/11/2023]
Abstract
The McCauley, a continuing care retirement community in West Hartford, CT, promotes a wellness philosophy that helps its residents retain their health and independence and extend their lives. The wellness program centers around the individual, not around the services provided. The residents have significant input and initiative in maintaining their own health. The health program is based on a nursing model, with each resident relating to a primary nurse as needs become evident. The nurses' goal is to know each person's holistic needs--to assist in maintaining physical, emotional, and spiritual balance. The program's approach to physical health requires a strong emphasis on prevention, including individualized fitness programs. The McCauley fosters mental and social well-being by allowing patients to maintain independent living for as long as they are able and by maximizing their self-direction. Another contributor to mental well-being is the opportunity for personal growth and intellectual stimulation. The McCauley promotes spiritual well-being by supporting continued participation in churches or synagogues from previous neighborhoods, fostering a supportive network within the community, and recognizing the value of residents' volunteer activities.
Collapse
|
50
|
Callaghan N, Crowley M, Goggin T. Epilepsy and employment, marital, education and social status. Ir Med J 1992; 85:17-9. [PMID: 1568840] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Employment, marital, educational and social status in epileptic patients attending a seizure clinic were assessed. A total of 343 patients were evaluated. The social group, employment and marital status did not compare favourably with the overall population. Forty per cent of patients belonged to social group five and six compared with 14% of the population. Thirty three per cent of male patients aged 20 years or more were married, compared with 65% in the community. The corresponding statistics for females were 46% and 73% respectively. The male unemployment rate of 34% compared poorly with the unemployment rate of 13% for the period during which the study data was collected. Patients with lower educational attainments were significantly more likely to have poor seizure control (P less than 0.001), or required polypharmacy. A similar situation was found between seizure control and social status, with poor seizure control occurring in patients in social group six.
Collapse
Affiliation(s)
- N Callaghan
- Department of Medicine, University College, Cork
| | | | | |
Collapse
|